Immunotherapy: Cancer vaccine therapy
Cancer vaccines come in several forms
Cancer vaccines are designed to stimulate the immune system to attack cancer cells that already exist.
In Japan, cancer vaccines are categorized into:
- Autologous cancer vaccines: formalin-fixed tumor tissue
- Dendritic cell therapy: with apheresis or without apheresis
- Artificial antigens: WT-1, MUC-1 and manu Tumor lysate
- Adjuvant: tuberculin, OK-432
- Injection: subcutaneous, intracutaneous
Cancer Vaccine Therapy
- Autologous cancer vaccine-derived from formalin-fixed or paraffin-embedded tissue fragments from a patient’s own cancer.
- Contains all the unknown cancer-associated antigens unique to a particular patient.
- Vaccine has potential in suppressing recurrence, preventing metastasis, and treating residual cancer cells in several human cancer types after surgical resection.
Preparation of autologous cancer vaccine
Following surgery, more than 2 grams of cancer tissue is used to elicit adequate immune response. At Saisei, we use adjuvants such as tuberculin and TuMP. The prepared vaccine needs to be injected every 1-2 weeks.
Cancer Vaccine Therapy
Preparation of dendric cell vaccine
First, the patient’s blood sample is taken and monocytes are cultivated in a cell processing center (CPC). Second, immature dendritic cells are isolated and mixed with tumor lysate or artificial antigens. Finally mature antigen-presenting dendritic cells are injected subcutaneously near the lymph nodes that are close to the cancer.
Reach us to get more information
Discover new methods of staying young, healthy and beautiful!
Contact us